CAS: 211915-06-9 - N-[2-[4-[N-(Hexyloxycarbonyl)amidino]phenylaminomethyl]-1-methyl-1H-benzimidazol-5-ylcarbonyl]-N-(2-pyridyl)-beta-alanine ethyl ester

Formel: C₃₄H₄₁N₇O₅

InChl: InChI=1S/C34H41N7O5/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44)

InChI Key: InChIKey=KSGXQBZTULBEEQ-UHFFFAOYSA-N

SMILES: O=C(OCCCCCC)NC(=N)C1=CC=C(C=C1)NCC2=NC=3C=C(C=CC3N2C)C(=O)N(C4=NC=CC=C4)CCC(=O)OCC

Synonyme:

• Alanine,N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester
• Bibr-1048
• Bibr-1048Ms
• Dabigatran etexilate
• Dabigatran etexilate mesylate base
• Dabigatran free base
• N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-Alanine, ethyl ester
• Pradaxa
• Prazaxa
• ethyl N-[(2-{[(4-{[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate
• β-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester
• β-Alanine,N-[[2-[[[4-[[[(hexyloxy)carbonyl] amino]iminomethyl] phenyl]amino] methyl]-1-methyl-1H-bezimidazol-5-yl]carbonyl]-N-2-pridinyl-ethyl ester

Dabigatran Etexilate

CAS: 211915-06-9

• Formel: C₃₄H₄₁N₇O₅
• Reinheit: >98.0%(T)(HPLC)
• Farbe und Form: White to Almost white powder to crystal
• Molekulargewicht: 627.75

Dabigatran etexilate

CAS: 211915-06-9

Dabigatran etexilate (BIBR 1048) is a thrombin inhibitor, which acts by binding and blocking thrombogenic …

• Formel: C₃₄H₄₁N₇O₅
• Reinheit: 98.19% - 99.12%
• Farbe und Form: White Powder
• Molekulargewicht: 627.73

Dabigatran Etexilate

CAS: 211915-06-9872728-81-9

• Formel: C₃₄H₄₁N₇O₅
• Farbe und Form: White To Off-White Solid
• Molekulargewicht: 627.75

Dabigatran Etexilate-d13(hexyloxy-d13)

CAS: 211915-06-9

• Reinheit: 98 atom % D
• Farbe und Form: White To Off White Solid
• Molekulargewicht: 640.82

Dabigatran etexilate

CAS: 211915-06-9

• Formel: C₃₄H₄₁N₇O₅
• Reinheit: ≥ 98.0%
• Farbe und Form: White to almost white powder or crystals
• Molekulargewicht: 627.73

Dabigatran-d4 Etexilate

CAS: 211915-06-9

• Formel: C₃₄H₃₇N₇O₅D₄
• Molekulargewicht: 631.77

Dabigatran Etexilate

CAS: 211915-06-9

Applications Dabigatran Etexilate is an oral anticoagulant and direct thrombin inhibitor. References Mangiafico, R. et …

• Formel: C₃₄H₄₁N₇O₅
• Farbe und Form: Neat
• Molekulargewicht: 627.73

Dabigatran Etexilate-d11

CAS: 211915-06-9

Stability Hygroscopic Applications Labeled Dabigatran Etexilate-d11, an oral anticoagulant and direct thrombin inhibitor. References Mangiafico, …

• Formel: C₃₄H₃₀D₁₁N₇O₅
• Farbe und Form: Neat
• Molekulargewicht: 638.8

Dabigatran etexilate - Bio-X ™

CAS: 211915-06-9

Dabigatran is an anticoagulant that is used for the treatment of atrial fibrillation and prevention …

• Formel: C₃₄H₄₁N₇O₅
• Reinheit: Min. 95%
• Farbe und Form: Powder
• Molekulargewicht: 627.73 g/mol

Dabigatran etexilate

CAS: 211915-06-9

Inhibits thrombin and trypsin; anti-thrombotic

• Formel: C₃₄H₄₁N₇O₅
• Reinheit: Min. 95%
• Farbe und Form: Powder
• Molekulargewicht: 627.73 g/mol